A newly surfaced internal memo from the U.S. Food and Drug Administration (FDA) has sparked debate after chief medical and scientific officer Vinay Prasad stated that COVID-19 vaccinations may have contributed to at least 10 cases of fatal heart inflammation in children. According to the memo, seen by Reuters, Prasad said the staff’s preliminary review suggested “likely, probable, or possible” vaccine attribution in these deaths. He described the findings as significant, noting it would mark the first time the FDA acknowledged potential fatal vaccine-related cases in American children.
The analysis reviewed 96 child deaths reported between 2021 and 2024. While it did not identify the children’s underlying medical conditions or the vaccine manufacturers involved, Prasad said that the early assessment found no fewer than 10 cases potentially linked to COVID-19 vaccination. He added that examining deaths involving children aged 7 to 16 was especially difficult.
Health Secretary Robert F. Kennedy Jr. has recently shifted U.S. vaccine policy, restricting access to COVID-19 vaccines to individuals 65 and older and those with certain conditions. Kennedy, long known for his skepticism toward vaccines, has criticized past vaccine policies promoted under both the Trump and Biden administrations.
Experts have urged caution in interpreting the memo. The FDA’s assessment has not been peer-reviewed or published in a medical journal, and critics—including UC Law San Francisco professor Dorit Reiss—argue that policy changes should not stem from unpublished investigations. Reiss also noted Prasad is not a vaccine specialist.
Despite concerns raised in the memo, FDA Commissioner Marty Makary emphasized that COVID-19 vaccines were highly effective for older adults, especially when matched to circulating variants. Recent research also supports the benefits of updated vaccines in reducing severe illness and hospitalization among high-risk groups.
CDC data shows 1,071 U.S. children aged 5 to 18 died from COVID-19 between early 2020 and mid-2023. Prasad argued that it remains unclear how vaccination influenced those outcomes, stating that voluntary reporting and unknown prevention metrics complicate comparisons.
The memo is expected to fuel continued discussion ahead of an upcoming CDC vaccine committee meeting.


Trump Administration Threatens Newark Airport International Travel Shutdown Over Immigration Dispute
Trump Signs Executive Order to Expand Access to Federal Lands in the U.S.
Peru Election 2026: Sanchez Takes Narrow Lead Over Fujimori
TrumpRx Expands Discount Drug Access With 600 Generic Medications
Lebanese President Urges Israel to Negotiate End to Conflict, Calls Military Approach Ineffective
Taiwan Simulates Repelling Chinese Invasion in Major Coastal Live-Fire Exercise
Alaska Senate Candidate Named Dan Sullivan Faces Investigation Over Alleged Voter Confusion Scheme
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access
Brazil Struggles to Stop Illegal Amazon Gold Mining as Gold Prices Surge
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand
FIFA Faces Investigation Over 2026 World Cup Ticket Pricing and Seat Allocation Issues
Why the future of marijuana legalization remains hazy despite high public support
US Appeals Court Allows Trump Military Enlistment Ban on Transgender Recruits, Protects Current Service Members
DOJ Opens Criminal Investigation Into E. Jean Carroll Over Alleged Perjury
Princess Anne’s Son Peter Phillips Marries Harriet Sperling at Royal Wedding in England
Trump Forced Labour Tariff Plan Faces Criticism as Experts Question Effectiveness 



